Oxygenta Pharmaceutical Ltd. | Small-cap | Healthcare
₹69.70
1.06%
| Oxygenta Stock Comparison:
Oxygenta vs Sun PharmaceuticalOxygenta vs Divi's LaboratoriesOxygenta vs Innova CaptabOxygenta vs Suven Life SciencesOxygenta vs Gujarat ThemisOxygenta vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 151.3M
Gross Profit -36.8M -24.33%
Operating Income -76.8M -50.72%
Net Income -61.1M -40.35%
EPS (Diluted) ₹-1.65

Balance Sheet Metrics

Total Assets 834.2M
Total Liabilities 1.1B
Shareholders Equity -250.2M

Cash Flow Metrics

Revenue & Profitability Trend

Oxygenta Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.1B396.4M309.9M605.2M520.3M
Cost of Goods Sold i1.1B409.9M305.8M565.7M423.0M
Gross Profit i16.7M-13.5M4.1M39.6M97.3M
Gross Margin % i1.5%-3.4%1.3%6.5%18.7%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i20.0M21.4M6.8M15.1M13.3M
Other Operating Expenses i21.5M488.0K7.9M1.8M2.9M
Total Operating Expenses i41.5M21.9M14.7M16.9M16.2M
Operating Income i-103.5M-123.7M-91.5M-1.2M26.5M
Operating Margin % i-9.5%-31.2%-29.5%-0.2%5.1%
Non-Operating Items
Interest Income i225.0K178.0K50.0K44.9K225.3K
Interest Expense i20.2M15.8M14.7M9.1M17.8M
Other Non-Operating Income-----
Pre-tax Income i-115.5M-138.7M-113.7M-4.9M31.4M
Income Tax i-18.7M-103.9M2.0M1.2M2.1M
Effective Tax Rate % i0.0%0.0%0.0%0.0%6.8%
Net Income i-96.8M-34.8M-115.7M-6.1M29.3M
Net Margin % i-8.9%-8.8%-37.3%-1.0%5.6%
Key Metrics
EBITDA i-84.5M-96.7M-71.1M14.7M39.3M
EPS (Basic) i₹-2.69₹-1.09₹-8.15₹-0.48₹2.87
EPS (Diluted) i₹-2.69₹-1.09₹-8.15₹-0.48₹2.87
Basic Shares Outstanding i3594651432039000142010001274376610201300
Diluted Shares Outstanding i3594651432039000142010001274376610201300

Income Statement Trend

Oxygenta Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i17.0K17.0K175.0K715.1K3.7M
Short-term Investments i1.2M991.0K887.0K841.7K800.0K
Accounts Receivable i51.0M73.6M101.6M15.8M16.1M
Inventory i205.1M137.2M117.1M72.8M121.1M
Other Current Assets1.0K-1.0K30.4M-118.9M
Total Current Assets i309.4M241.1M250.1M95.6M159.4M
Non-Current Assets
Property, Plant & Equipment i14.4M13.4M12.5M12.1M11.1M
Goodwill i0-0--
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets-574-1.0K-1.0K1-
Total Non-Current Assets i524.8M390.9M292.6M216.1M179.2M
Total Assets i834.2M631.9M542.6M311.8M338.6M
Liabilities
Current Liabilities
Accounts Payable i297.9M228.9M237.8M64.6M137.9M
Short-term Debt i407.1M82.3M57.4M10.9M28.5M
Current Portion of Long-term Debt-----
Other Current Liabilities3.6M2.8M4.4M3.2M2.9M
Total Current Liabilities i858.5M337.0M329.0M80.7M175.0M
Non-Current Liabilities
Long-term Debt i215.2M490.0M622.5M510.4M450.4M
Deferred Tax Liabilities i-016.6M14.6M13.4M
Other Non-Current Liabilities--1.0K-1.0K00
Total Non-Current Liabilities i226.0M496.2M675.7M577.4M543.9M
Total Liabilities i1.1B833.1M1.0B658.1M718.8M
Equity
Common Stock i369.8M334.8M142.0M142.0M102.0M
Retained Earnings i-735.6M-638.8M-604.0M-488.3M-482.2M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i-250.2M-201.2M-462.0M-346.3M-380.2M
Key Metrics
Total Debt i622.3M572.3M679.9M521.3M478.9M
Working Capital i-549.0M-95.9M-78.9M15.0M-15.5M

Balance Sheet Composition

Oxygenta Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i-115.5M-138.7M-113.7M-4.9M31.4M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i49.7M4.4M-150.0M53.9M-157.6M
Operating Cash Flow i-61.1M-118.5M-248.9M58.2M-108.6M
Investing Activities
Capital Expenditures i-112.7M-41.1M-96.4M-49.5M-67.4M
Acquisitions i-----
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-112.7M-41.1M-96.4M-49.5M-67.4M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i379.3M294.9M-1.0K40.0M0
Free Cash Flow i-87.9M-171.6M-112.8M-66.3M-83.6M
Net Change in Cash i205.5M135.3M-345.4M48.8M-176.0M

Cash Flow Trend

Oxygenta Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 444.32
Price to Book -10.31
Price to Sales 2.22
PEG Ratio 1.38

Profitability Ratios

Profit Margin -13.45%
Operating Margin -50.72%
Return on Equity 38.69%
Return on Assets -11.61%

Financial Health

Current Ratio 0.36
Debt to Equity -2.49
Beta 0.42

Per Share Data

EPS (TTM) ₹-3.95
Book Value per Share ₹-7.15
Revenue per Share ₹30.62

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
oxygentaph2.6B444.32-10.3138.69%-13.45%-2.49
Sun Pharmaceutical 4.0T37.735.4215.08%19.29%3.26
Divi's Laboratories 1.6T67.5710.4014.64%23.89%0.03
Innova Captab 48.6B37.445.0713.37%9.98%35.24
Suven Life Sciences 48.0B-28.3141.36-146.15%84.44%0.00
Gujarat Themis 46.2B103.1518.5519.64%30.17%12.27

Financial data is updated regularly. All figures are in the company's reporting currency.